EC

European Commission — EudraLex

European UnionEuropeNational / regional regulator

Publisher of EudraLex Volume 4 (EU GMP Guide and its Annexes) and the EU GDP Guidelines.

Browse the standards library →Official site ↗

WHAT EC COVERS

The European Commission is the EU’s executive and the source of the binding legal framework for medicines — Directive 2001/83/EC for human medicines, Directive 2001/82/EC and Regulation (EU) 2019/6 for veterinary, and Regulation (EC) No 726/2004 establishing the centralised procedure. It adopts the GMP guidelines that member-state inspectorates enforce and takes the legal decisions on centralised marketing authorisations.

WHERE IT SITS INTERNATIONALLY

The EU framework is the reference for PIC/S PE 009, which mirrors the EU GMP Guide closely, and adopts ICH guidelines into EudraLex. That triangle is why a site built to EU GMP is broadly aligned across most of the world.

HOW ITS REQUIREMENTS BITE

The Commission legislates rather than inspects. Its instruments take effect through member states: a Regulation applies directly across the Union, while a Directive is transposed into national law. GMP and GDP guidelines published in EudraLex Volume 4 are then applied by the national competent authorities during inspection, which is why the enforcement you experience is national even though the requirement is European.

WHAT EC PUBLISHES

  1. 01EudraLex Volume 4 — the EU GMP Guide, Parts I–III and the Annexes (Annex 1 sterile, Annex 11 computerised systems, Annex 15 qualification and validation, Annex 16 QP certification)
  2. 02EU Good Distribution Practice guidelines (2013/C 343/01)
  3. 03Directives and Regulations forming the pharmaceutical acquis
  4. 04Commission Implementing Regulations — including (EU) No 520/2012 on pharmacovigilance
  5. 05The Notice to Applicants and other procedural guidance

WHAT PRACTITIONERS GET WRONG

  • The GMP Annexes carry most of the operational detail — Annex 1 (2022) reshaped sterile manufacturing expectations.
  • A Regulation applies directly; a Directive must be transposed, so national implementations can differ in detail and timing.
  • EudraLex Volume 4 Part III holds the ICH texts (Q9, Q10) as adopted EU documents.
  • Do not conflate the Commission (legislator), EMA (scientific coordination), and national authorities (inspection).

EC STANDARDS SPEQ DECODES · 5

Directive 2004/10/EC
Harmonisation of Laws Relating to the Application of GLP
2013/C 343/01HIGH INSPECTION RISK
EU Guidelines on Good Distribution Practice of Medicinal Products
Regulation (EU) 2019/6
Veterinary Medicinal Products
Regulation (EU) 2017/745HIGH INSPECTION RISK
Medical Device Regulation (MDR)
Regulation (EC) No 1223/2009
EU Cosmetic Products Regulation

DISCIPLINES IN EC’S REMIT

GMPGood Manufacturing PracticeGLPGood Laboratory PracticeGDPGood Distribution PracticeQMSQuality Management Systems
Weekly Briefing

Track EC — and every regulator that matters

New rules, guidance, enforcement, and inspection signals from European Commission — EudraLex and its peers worldwide, distilled into the free Weekly GxP Briefing.

Read a past issue →